Structure based drug design for HIV protease: from molecular modeling to cheminformatics

Area of Science:

• Computational chemistry and molecular modeling.
• Drug discovery and development.
• Bioinformatics and cheminformatics.

Background:

• Advances in virtual molecular representations have enabled structure-based drug design.
• Virtual screening techniques are crucial for identifying potential drug candidates.
• The development of antiviral drugs for HIV protease serves as a key success story.

Purpose of the Study:

• To review progress and methods in virtual screening for drug discovery.
• To highlight the importance of molecular structure and property representation.
• To discuss challenges and future directions in computational drug design.

Main Methods:

• Ranking ligand affinity to target proteins using computational methods.
• Employing molecular modeling of target proteins with ligands.
• Utilizing database docking of molecules to target protein sites.
• Developing algorithms for molecular representation and similarity searching.

Main Results:

• Virtual screening has successfully led to the development of drugs, such as for HIV protease.
• Computational speed and prediction accuracy depend on molecular representation, algorithms, and scoring functions.
• Integration of diverse data (genomic, proteomic, chemical, pharmacological) is essential.

Conclusions:

• Virtual screening is a powerful tool in modern drug discovery.
• Continued development of computational tools, algorithms, and machine learning is vital for improving prediction accuracy and managing large datasets.
• Structure-based drug design, aided by virtual screening, holds significant promise for identifying novel therapeutics.